WeightCare Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.5/10
Best for: starting below a standard dose, with microdose tiers
WeightCare falls below our bar on oversight: the FDA has issued it a warning letter. Read the breakdown below before you give it money.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
charged as a multi-month plan up front
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked August 2026
WeightCare charges $249-$399/mo for compounded semaglutide and $349/mo for tirzepatide, dispensed by FDA-registered, PCAB-accredited pharmacies. The company is based in Ft. Lauderdale, FL, and says it has taken on 85,000+ members since 2022. It publishes quality testing documentation covering potency and sterility per USP 797.
Is WeightCare legit?
WeightCare is a real, operating US company, and the FDA has issued it a warning letter. The letter is summarized at the top of this review. Read what it alleges before you decide, and raise it with the clinician who would prescribe for you. We rate WeightCare 6.5/10 overall.
Is there a WeightCare promo or coupon code?
We know of no promo or coupon code for WeightCare. Its listed price is $215 a month. Coupon sites advertising "WeightCare discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how WeightCare compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to WeightCare
Editorial score · methodology
Editorial score · methodology
Embody
Best for: knowing which pharmacy fills the vial: it names RedRock Pharmacy
Editorial score · methodology
WeightCare at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $215/mo (6-month plan)
- What's included
- Medication · Consult · Shipping
- FDA status
- 1 FDA warning letter (details below)
How WeightCare scores
Six columns, each one computed from something WeightCare has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
4.3/10$275/month is 10% above the $250 median for compounded tirzepatide across the sellers we compare. That figure is a multi-month plan paid up front, not a month-to-month rate, so the comparison flatters it.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
3.5/10The FDA has issued it a warning letter. No pharmacy is named for its prescriptions. It shows a price before asking for health information.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on WeightCare
Last checked August 2026- Checked the listed price across 9 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for WeightCare
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with WeightCare involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1WeightCare shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask WeightCare which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits and shipping.
- Lowest ongoing monthly price: semaglutide $215, tirzepatide $275. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that WeightCare serves your state before you start.
- The FDA has issued WeightCare a warning letter. It is covered in the enforcement section below; read what it alleges before you decide.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting WeightCare
- WeightCare offers email support
- Hours
- M-F 9AM-6PM EST
Cancelling WeightCare
Taken from the terms WeightCare publishes. Terms change, so check the current policy before you subscribe.
- Minimum commitment
- None
- Refund policy
- Not published by the seller
GLP-1 medications WeightCare offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
month-to-month, no commitment
3-month plan ($747); new patients & starter doses only
6-month plan
micro-dose program
month-to-month, covers all doses
3-month plan; standard dose; up to $333/mo
6-month plan; standard dose
3-month high-dose plan ($1,350)
6-month high-dose plan ($2,150)
Check the price yourself before you pay
Every figure here was read off WeightCare's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Tirzepatide costs $275 a month, close to the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
Against it
- Semaglutide costs $215 a month, 16% above the $185 median for compounded semaglutide across the sellers we compare
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued WeightCare a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What WeightCare charges
WeightCare charges $215/month.
- Compounded semaglutide: $399/month
- Compounded semaglutide: $249/month
- Compounded semaglutide: $215/month
- Compounded semaglutide: $249/month
- Compounded tirzepatide: $499/month
- Compounded tirzepatide: $299/month
For compounded tirzepatide, the median across the sellers we compare is $250/month, so WeightCare's $275 lands mid-market. Price is unlikely to be the deciding factor.
HumeCare+ dispenses semaglutide and tirzepatide from $199/month, which makes it the fair comparison to run before you commit here.
What WeightCare dispenses
WeightCare prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it.
Safety and disclosure
WeightCare tells you its price before you start the medical questionnaire and that its pharmacy is accredited. The FDA has issued WeightCare a warning letter, summarized at the top of this page. A letter flags a problem rather than ruling a seller out, so read what it says before deciding what it means for you. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If WeightCare will not tell you, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether WeightCare bills your plan before you start.
- A seller's regulatory history matters to you more than price. Read the warning letter summarized above before deciding.
Our read
WeightCare lands mid-market on price. The catch is disclosure, which is why WeightCare scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you. Whatever you decide, read the warning letter summarized at the top of this page first, and raise it with the clinician who would prescribe for you.
The Bottom Line
WeightCare falls below our bar on oversight: the FDA has issued it a warning letter. Read the breakdown below before you give it money.
Before you pay WeightCare
Starting at $215 a month. Check today's price, then start the intake.
Where WeightCare is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider Sesame Care.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo).
- If you want a human checking in, not just a prescription, consider ShedRx.
Compare WeightCare head to head
The sellers closest to WeightCare on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
WeightCare has an FDA warning letter on record, dated February 20, 2026
This letter concerns false & misleading claims/misbranded. A warning letter is public correspondence from FDA, not an adjudication. On its own it establishes no finding of illegal activity, and a company that gets one often answers with corrective action.
Sources
Cited across this WeightCare review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See WeightCare's current pricing
Plans start at $215 a month. Whether you qualify is a clinician's decision, made after your intake.